Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
First published online: 12 December 2016, Int J Epidemiol, 2016, doi: https://doi.org/10.1093/ije/dyw275 The reported hazard ratios for two of the 46 papers included in this systematic review were incorrect. The estimates from Currie et al (2009) (reference 3) and Currie et al (2013) (reference 47) should have been inverted. This error affected some of the results reported in the abstract and the main text; the relevant data points on Figures 2, 3 and 4 and in the supplementary table; some of the data in Table 4; and one sentence in the discussion. All these items have now been corrected. The key results and conclusions were unaffected by this error.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bladder cancer risk may be higher in men.1766”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1766]
In the citing paper
“T2D has been shown to be associated with increased risk for hepatic,1765 bladder,1766 pancreatic,1767,1768 and colorectal cancers.1769”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1766]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua, Y., Zheng, Y., Yao, Y., Jia, R., Ge, S., & Zhuang, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04263-8 · Cited by 199
Promises and pitfalls of electronic health record analysis
Farmer, R. E., Mathur, R., Bhaskaran, K., Eastwood, S. V., Chaturvedi, N., & Smeeth, L. L. (2017) · Diabetologia · doi:10.1007/s00125-017-4518-6 · Cited by 136
Self-citationTang, G. H., Satkunam, M., Pond, G. R., Steinberg, G. R., Blandino, G., Schünemann, H. J., & Muti, P. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0936 · Cited by 117
Bjornsdottir, H. H., Rawshani, A., Rawshani, A., Franzén, S., Svensson, A.-M., Sattar, N., & Gudbjörnsdottir, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-73668-y · Cited by 110
Metadata
- Authors
- Farmer, R. E., Ford, D., Forbes, H. J., Chaturvedi, N., Kaplan, R., Smeeth, L., & Bhaskaran, K.
- Corresponding author
- Farmer, Ruth E
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-01
- Volume
- 46
- Issue
- 2
- Pages
- 745-745
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W4233765007
- Cited by
- 59
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 11 · 2023: 7 · 2022: 6 · 2021: 2 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 4
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- International Journal of Epidemiology (publishedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (107731/Z/15/Z)
- National Institute for Health and Care Research (NIHR/CS/010/014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- metformin, type 2 diabetes, cancer risk, diabetes and cancer association, hazard ratio, bias assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation. https://app.cochat.ai/papers/10.1093/ije/dyx046
- The paper
- Farmer, R. E., Ford, D., Forbes, H. J., Chaturvedi, N., Kaplan, R., Smeeth, L., & Bhaskaran, K. (2017). Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyx046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.